Keyphrases
Israel
100%
Survivors
100%
Epidemiology
100%
Non-Hodgkin Lymphoma
100%
Second Malignancy
100%
Jews
55%
Arab
33%
Hematological Malignancies
22%
Secondary Haematological Malignancies
22%
Israeli
11%
Jewish
11%
High Risk
11%
Risk Factors
11%
Arab Women
11%
Genetic Predisposition
11%
Solid Tumors
11%
Lymphoma Patients
11%
Arab Men
11%
Jewish Women
11%
Patients Included
11%
National Cancer Registry
11%
Standardized Incidence Ratio
11%
Age of Diagnosis
11%
Factor Combination
11%
Leukemia-lymphoma
11%
Second Cancer
11%
Genetic Susceptibility
11%
Arab Cardiovascular Patients
11%
Tumor Malignancy
11%
Immunological Status
11%
Immunologic Therapy
11%
Molecular Background
11%
Hodgkin Lymphoma Survivors
11%
Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Cohort Effect
100%
Second Cancer
100%
Hematologic Malignancy
40%
Population
10%
Genetic Predisposition
10%
Solid Malignant Neoplasm
10%
Leukemia
10%
Cancer Registry
10%
Standardized Incidence Ratio
10%
Genetic Susceptibility
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nonhodgkin Lymphoma
100%
Second Cancer
100%
Hematologic Malignancy
40%
Leukemia
10%
Solid Malignant Neoplasm
10%
Cancer Registry
10%
Genetic Predisposition
10%
Standardized Incidence Ratio
10%
Genetic Susceptibility
10%